Dysport® Injections

Dysport® injections are an FDA-approved treatment for reducing the appearance of frown lines between the eyebrows, as well as the forehead and around the lips. This neurotoxin temporarily blocks chemical communications that trigger forehead contractions, reducing muscle activity and smoothing fine lines and wrinkles. Our surgically trained team of physician assistants use Dysport® to help restore a softer, more youthful-looking appearance.

Treatment Areas

Dysport® injections are minimally invasive, can be completed in just 10 minutes, and require no recovery period. While you should refrain from strenuous exercise and remain upright for a few hours after treatment to ensure your injections settle correctly, you can resume most activities immediately following your appointment. Dysport® injections are commonly used to treat lines and wrinkles in the following areas:

Glabellar lines (the “11s”)


Forehead lines


Perioral lines (the “lipstick lines”)

Dysport® vs. Other Injectables

Dysport® is a frequently used brand of wrinkle-reducing injectable, but it’s not the only choice. Here are three other alternatives to compare:


Unlike other botulinum toxin treatments, Xeomin® does not include additional proteins, which means patients are less likely to develop a tolerance. Xeomin is an excellent option if you no longer see results with similar treatments.
botox (2)


Although Botox is similar to Dysport®, it has larger and slower-moving molecules. In other words, while Dysport® works better spreading across larger areas, like the forehead, Botox performs well on smaller areas.


Other wrinkle-reducing neurotoxin treatments were developed for medical use first, then approved for cosmetic procedures. Jeuveau was created solely for aesthetics and is also one of the newest treatments on the market.

Is Dysport® right for me?

Dysport® is recommended for people between 18 and 65 who want to reduce the appearance of frown lines. It may not be appropriate for people with certain medical conditions. As with all injectable treatments, you may experience mild swelling, bruising, bleeding, or redness at the injection site. However, these side effects are usually minimal and resolve within a day or two.

The Beauty Benefits of Dysport®

As we age, our skin naturally begins to lose elasticity. As such, repetitive facial expressions, such as frowning, can create wrinkles and fine lines. For individuals who want to soften these lines, a few Dysport® injections between and above the eyebrows can relax targeted muscles for up to five months. Most individuals see results within two to three days after treatment.

Dysport® Near Me

If you’ve been searching for “Dysport® injections near me,” you can rest assured you’re in the right place. Our team of medically trained expert injectors can help you achieve your unique aesthetic goals.


Is Dysport® safe?
Studies show botulinum toxin treatments like Dysport® are widely viewed as safe and effective, so long as they are injected properly by an experienced professional.1
How much Dysport® will I need?
Many patients see significant improvements to frown lines with just five injections between and above the eyebrows. However, our team customizes all treatment plans to each patient’s unique goals.
Will results look natural?
Our team is trained in surgical precision and will ensure natural-looking results. We want to help you look youthful and radiant without changing your facial appearance.
Will Dysport® hurt?
While some patients report feeling a small pinch with each injection, you should not feel any significant or prolonged discomfort.
Should I do anything to prepare for Dysport®?

It’s best to avoid alcohol for at least 48 hours before your appointment, and do not take any over-the-counter pain medicines except Tylenol for at least three days. We also discourage using topical Vitamin A products like Retin-A or Tretinoin or taking supplements, such as Vitamin A, Vitamin E, CoQ10, Omega-3 fatty acids, or cod liver oil, for up to four days before your treatment.

According to a study published in Advances in Dermatology and Allergology